• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    New Oracle Cloud Services Help Pharmas Accelerate Clinical Trial Site Feasibility Assessment and Patient Recruitment

    10/29/24 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology
    Get the next $ORCL alert in real time by email

    Developments are the latest in Oracle's commitment to bridge the gap between clinical research and patient care to help speed the development of and access to breakthrough treatments   

    NASHVILLE, Tenn., Oct. 29, 2024 /PRNewswire/ -- Oracle Health Summit -- To help life sciences organizations accelerate and reduce the cost and complexity of clinical trials so they can get lifesaving treatments to market faster, Oracle Life Sciences today announced Oracle Site Feasibility and Oracle Patient Recruitment Cloud Services. Running on Oracle Cloud Infrastructure (OCI), the new Oracle Life Sciences services benefit from best-in-class security and trust in handling and storing Protected Health Information in compliance with HIPAA regulations. In addition, OCI's high performance and availability mean these new solutions, coupled with Oracle's Real World Data assets and life science and clinical applications, help pharmaceutical companies, CROs and researchers to select clinical trial sites and recruit patients more quickly.

    (PRNewsfoto/Oracle)

    "Patient recruitment is the cornerstone of any clinical trial, but identifying the right sites and recruiting the right patients at scale is difficult, time-consuming, and costly," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "Our new site feasibility and patient recruitment cloud services are an example of how Oracle's extensive expertise in life sciences and healthcare are bridging the gap between clinical research and patient care. We can provide insights based on our secure, authorized, and vast Electronic Health Record data that helps sponsors and CROs to intelligently select clinical trial sites and enable site study teams to identify and enroll qualified patients more efficiently and effectively."

    According to Deloitte research1, patient recruitment accounts for 32% of clinical trial costs, making it the largest expense in the process. Additionally, $1.9 billion is spent on recruitment annually,2 even though 72% of trial participants are already patients at a site. Oracle Site Feasibility and Oracle Patient Recruitment can help life sciences organizations overcome these challenges and dramatically reduce the cost of running clinical trials.

    Through the existing Study Startup solution and Oracle's extensive deidentified Electronic Health Record (EHR) data from participating healthcare systems, Oracle Site Feasibility Cloud Service enables life sciences organizations to quickly and easily identify the most advantageous sites for their clinical trials. Within activated clinical trial sites, Oracle Patient Recruitment Cloud Service can increase enrollment efficiency by informing authorized study teams of identified patients within their health system who could potentially meet trial criteria based on their clinical profile.

    Activate sites faster and accelerate study timelines

    With Oracle Site Feasibility, life science organizations can accelerate the site-selection process and have more visibility into untapped sites. The new service enables life science organizations to more quickly find viable clinical trial site locations by surfacing trial-specific eligible and partially eligible patients from participating healthcare facilities. This solution uses Oracle's deidentified EHR clinical data to run feasibility queries across patient records, analyzing key data points, such as past site performance and qualified patients per site. This data granularity helps life science organizations to intelligently select sites with the highest volume of potential eligible patients.

    Recruit the right patients more quickly

    Oracle Patient Recruitment is available globally for life sciences customers to help activate sites faster and provide deeper patient insights to help study teams be more aware of any retention or dropout risks and recruit the right patients for the trial. It uses Health Data Intelligence (HDI) as its underlying technology infrastructure to surface data directly from the EHR and identify eligible and partially eligible patients for potential trial participation.

    Oracle Patient Recruitment calculates an eligibility score for qualified patients and provides important insights to the study team about why a patient qualifies for a trial or where they may fall short. This level of detail lets study teams quickly identify what next steps should be taken with the trial candidate and eliminates time wasted searching for additional context in the medical record. Oracle Patient Recruitment also incorporates health system registration and scheduling data, giving study teams visibility to upcoming and past appointment details. Using these additional insights, the study team can customize a visit schedule based on the patient's unique situation to help ensure the patient does not drop out – another step in putting the patient's care first. 

    For more information about Oracle Site Feasibility and Oracle Patient Recruitment Cloud Services, visit: https://www.oracle.com/life-sciences/

    To join segments of the Oracle Health Summit virtually, visit: https://www.oracle.com/health/health-summit/

    About Oracle Life Sciences

    Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the life sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences

    About Oracle

    Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

    Trademarks

    Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

    1 Taylor K, Properzo, F, et al. Intelligent clinical trials. Deloitte Centre for Health Insights. 2020. https://www2.deloitte.com/content/dam/insights/us/articles/22934_intelligent-clinical-trials/DI_Intelligent-clinical-trials.pdf

    2
    Idnay B, Fang Y, Butler A, et al. Uncovering key clinical trial features influencing recruitment. J Clin Transl Sci. 2023 Sep 4;7(1):e199. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565197/

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/new-oracle-cloud-services-help-pharmas-accelerate-clinical-trial-site-feasibility-assessment-and-patient-recruitment-302289032.html

    SOURCE Oracle

    Get the next $ORCL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Q&A

    New
    • What are the new services announced by Oracle Life Sciences?

      Oracle has launched new services named Oracle Site Feasibility and Oracle Patient Recruitment Cloud Services to aid life sciences organizations in accelerating clinical trials and reducing costs.

    • How does Oracle Site Feasibility Cloud Service assist organizations?

      The Oracle Site Feasibility Cloud Service helps organizations quickly identify the best sites for clinical trials, leveraging deidentified Electronic Health Record data.

    • What percentage of clinical trial costs is attributed to patient recruitment?

      Patient recruitment accounts for 32% of clinical trial costs, which is the largest single expense in the clinical trial process.

    • What is the primary goal of the Oracle's new clinical trial services?

      The new services aim to improve efficiency in selecting clinical trial sites and rapidly recruiting suitable patients to ensure timely access to treatments.

    • What technology does the Oracle Patient Recruitment Cloud Service utilize to identify qualified patients?

      Oracle Patient Recruitment uses Health Data Intelligence technology to analyze patient records and calculate eligibility scores for potential trial candidates.

    Recent Analyst Ratings for
    $ORCL

    DatePrice TargetRatingAnalyst
    6/18/2025$220.00 → $250.00Buy
    Guggenheim
    6/13/2025$235.00Market Perform → Outperform
    BMO Capital Markets
    6/9/2025$175.00 → $200.00Market Perform
    BMO Capital Markets
    4/23/2025$130.00Overweight → Neutral
    Piper Sandler
    3/19/2025$167.00Equal-Weight
    Stephens
    3/11/2025$205.00 → $175.00Market Perform
    BMO Capital Markets
    3/3/2025Sell → Neutral
    Monness Crespi & Hardt
    1/17/2025$214.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $ORCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Conrades George H sold $1,744,000 worth of shares (8,169 units at $213.49), decreasing direct ownership by 18% to 38,456 units (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      6/20/25 5:49:14 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • President, OCI Magouyrk Clayton M. sold $3,211,484 worth of shares (15,000 units at $214.10), decreasing direct ownership by 20% to 60,722 units (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      6/20/25 5:48:21 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Vice Chairman Henley Jeffrey exercised 400,000 shares at a strike of $40.36 and sold $76,169,016 worth of shares (400,000 units at $190.42) (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      6/13/25 4:29:29 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Guggenheim reiterated coverage on Oracle with a new price target

      Guggenheim reiterated coverage of Oracle with a rating of Buy and set a new price target of $250.00 from $220.00 previously

      6/18/25 9:35:56 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Oracle upgraded by BMO Capital Markets with a new price target

      BMO Capital Markets upgraded Oracle from Market Perform to Outperform and set a new price target of $235.00

      6/13/25 7:44:59 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • BMO Capital Markets reiterated coverage on Oracle with a new price target

      BMO Capital Markets reiterated coverage of Oracle with a rating of Market Perform and set a new price target of $200.00 from $175.00 previously

      6/9/25 8:24:53 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    SEC Filings

    See more
    • SEC Form 144 filed by Oracle Corporation

      144 - ORACLE CORP (0001341439) (Subject)

      6/20/25 4:09:32 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-K filed by Oracle Corporation

      10-K - ORACLE CORP (0001341439) (Filer)

      6/18/25 4:31:22 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 144 filed by Oracle Corporation

      144 - ORACLE CORP (0001341439) (Subject)

      6/17/25 4:04:03 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AI Innovators Worldwide Choose Oracle for AI Training and Inferencing

      Fireworks AI, Hedra, Numenta, and Soniox experience accelerated performance and cost efficiency with Oracle Cloud Infrastructure AUSTIN, Texas, June 18, 2025 /PRNewswire/ -- AI innovators across the world are using Oracle Cloud Infrastructure (OCI) AI infrastructure and OCI Supercluster to train AI models and deploy AI inference and applications. Fireworks AI, Hedra, Numenta, Soniox, and hundreds of other leading AI innovators have selected OCI for its scalability, performance, cost efficiency, choice of compute instances, and control over where to run their AI workloads. As

      6/18/25 8:00:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Oracle Health Community Care Improves Care in Mobile, Home, and Rural Settings

      The mobile technology enables access to vital patient information regardless of network connectivity and location   AUSTIN, Texas, June 17, 2025 /PRNewswire/ -- Oracle today announced the general availability of Oracle Health Community Care, a cloud-based mobile extension of the Oracle Health Foundation electronic health record (EHR). The new offering enables caregivers to securely access and update comprehensive patient charts regardless of network connectivity, so nurses, therapists, dieticians, social workers, and physicians have the information they need to perform in-home patient visits, provide care in mobile clinics, or undertake emergency interventions.

      6/17/25 9:15:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • xAI's Grok Models are Now on Oracle Cloud Infrastructure

      Customers can now harness Grok models via OCI Generative AI service to tackle complex problems Powered by OCI AI infrastructure, Grok models will leverage OCI Compute instances with significant price-performance and scalability advantages AUSTIN, Texas, June 17, 2025 /PRNewswire/ -- xAI has selected Oracle to offer xAI's Grok models via Oracle Cloud Infrastructure (OCI) Generative AI service for a wide range of use cases, including content creation, research, and business process automation. xAI will also leverage the scalability, performance, and cost efficiency of OCI's leading AI infrastructure to train and run inferencing for its next-generation Grok models.

      6/17/25 8:00:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      3/21/25 8:43:30 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Director Moorman Charles W bought $947,913 worth of shares (5,500 units at $172.35) (SEC Form 4)

      4 - ORACLE CORP (0001341439) (Issuer)

      2/14/25 4:41:16 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

      SC 13G/A - ORACLE CORP (0001341439) (Subject)

      2/9/24 4:33:37 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

      SC 13G/A - ORACLE CORP (0001341439) (Subject)

      2/10/23 4:31:02 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

      SC 13G/A - ORACLE CORP (0001341439) (Subject)

      2/10/22 8:28:11 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Leadership Updates

    Live Leadership Updates

    See more
    • SoftBank Group to Acquire Ampere Computing

      SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

      3/19/25 7:30:00 PM ET
      $CG
      $ORCL
      Investment Managers
      Finance
      Computer Software: Prepackaged Software
      Technology
    • Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

      Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi

      10/30/24 9:00:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Meharry Medical College and Oracle Collaborate to Advance Healthcare Access, Innovation, and Education

      Oracle is collaborating with Meharry Medical College regarding technology and resources for students and providers, a research collaborative, and a Meharry established community clinic and wellness center NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle Health and Meharry Medical College today announced plans to improve medical education and community healthcare across Middle Tennessee and beyond. As part of their non-binding MOU, Meharry and Oracle aim to establish a health technology education and research collaborative, a health innovation hub, and a community care and wellness center in Nashville. The two organizations will also work together to cultivate th

      10/30/24 8:55:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology

    $ORCL
    Financials

    Live finance-specific insights

    See more
    • Oracle Announces Fiscal 2025 Fourth Quarter and Fiscal Full Year Financial Results

      Q4 Remaining Performance Obligations up 41% to $138 billionQ4 GAAP Earnings per Share $1.19, non-GAAP Earnings per Share $1.70Q4 Total Revenue $15.9 billion, up 11%Q4 Cloud Revenue (IaaS plus SaaS) $6.7 billion, up 27%Q4 Cloud Infrastructure (IaaS) Revenue $3.0 billion, up 52%Q4 Cloud Application (SaaS) Revenue $3.7 billion, up 12%Q4 Fusion Cloud ERP (SaaS) Revenue $1.0 billion, up 22%Q4 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 18%FY 2025 Total Revenue $57.4 billion, up 8%AUSTIN, Texas, June 11, 2025 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced fiscal 2025 Q4 and full-year 2025 results. Total quarterly revenues were up 11% year-over-year in USD and constant curren

      6/11/25 4:05:00 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Oracle Sets the Date for its Fourth Quarter Fiscal Year 2025 Earnings Announcement

      Earnings Results to be released on June 11, 2025, After the Close of the Market AUSTIN, June 3, 2025 /PRNewswire/ -- Oracle Corporation today announced that its fourth quarter and fiscal year 2025 results will be released on Wednesday, June 11th, after the close of the market.  Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About Oracle Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

      6/3/25 4:00:00 PM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology
    • Izzi Improves Customer Experience and Revenue Growth with Oracle

      Mexican telecommunications operator reduces bill run times by 70% and achieves greater agility with Oracle Digital Business Experience on Oracle Cloud Infrastructure MEXICO CITY and AUSTIN, Texas, May 1, 2025 /PRNewswire/ -- Izzi, a subsidiary of Televisa Group, is modernizing its business support systems (BSS) in the cloud to bolster customer experience. By upgrading to the latest version of Oracle Communications Digital Business Experience running on Oracle Cloud Infrastructure (OCI), Izzi has reduced billing times by 70% and invoicing times by 60%, allowing the company to receive payments faster and improve cash flow. Izzi embarked on its modernization and cloud migration journey with su

      5/1/25 8:00:00 AM ET
      $ORCL
      Computer Software: Prepackaged Software
      Technology